Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less

  • Park, Young-A (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kim, Nam-Kyun (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Park, Su-Jin (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Yun, Bong-Sic (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Choi, Jae-Young (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Sul, Jun-Hee (Division of Pediatric Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System)
  • Received : 2010.09.15
  • Accepted : 2010.10.26
  • Published : 2010.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Transcatheter closure has become an effective therapy in most patients with patent ductus arteriosus (PDA). However, there are difficulties in transcatheter closure of PDA in small children. We reviewed clinical outcomes of transcatheter closure of PDA in children weighing less than 10 kg in a single center. Methods: Between January 2003 and December 2009, 314 patients with PDA underwent transcatheter closure in our institute. Among them, 115 weighed less than 10 kg. All of these patients underwent transcatheter closure of PDA using either COOK Detachable $Coil^{(R)}$, PFM Nit-$Occlud^{(R)}$, or Amplatzer duct $occluder^{(R)}$. A retrospective review of the treatment results and complications was performed. Results: The mean age of patients was $9.1{\pm}5.9$ months (median, 8 months), and mean weight was $7.6{\pm}1.8kg$ (median, 7.8 kg). The mean diameter of PDA was $3.2{\pm}1.4mm$ (median, 3 mm). Complete occlusion occurred in 113 patients (98%). One patient was sent to surgery because of a failed attempt at device closure, and another patient had a small residual shunt after device placement. The average mean length of hospital stay was $3.0{\pm}3.3$ days, and mean follow-up duration was $21.0{\pm}19.6$ months. There were no major complications in any of the patients. Conclusion: Transcatheter closure of PDA is considered safe and efficacious in infants weighing less than 10 kg. With sufficient experience and further effort, transcatheter closure of PDA can be accepted as the gold standard of treatment for this group of patients.

Keywords

References

  1. Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon 1967;12:259-61.
  2. Kim Y, Choi JY, Lee JK, Sul JH, Lee SK, Park YH, et al. Mid-term result of the transcatheter occlusion of patent ductus arteriosus with Duct-Occlud device and procedure-related problems. Korean J Pediatr 2004;47:36-43.
  3. Jang GY, Son CS, Lee JW, Lee JY, Kim SJ. Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci 2007;22:484-90. https://doi.org/10.3346/jkms.2007.22.3.484
  4. Fischer G, Stieh J, Uebing A, Grabitz R, Kramer HH. Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder. Heart 2001;86:444-7. https://doi.org/10.1136/heart.86.4.444
  5. Al-Ata J, Arfi AM, Hussain A, Kouatli AA, Jalal MO. The efficacy and safety of the Amplatzer ductal occluder in young children and infants. Cardiol Young 2005;15:279-85. https://doi.org/10.1017/S1047951105000570
  6. Butera G, De Rosa G, Chessa M, Piazza L, Delogu A, Frigiola A, et al. Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart 2004;90:1467-70. https://doi.org/10.1136/hrt.2003.025122
  7. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol 2001;37:258-61. https://doi.org/10.1016/S0735-1097(00)01094-9
  8. Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation 1987;75:583-92. https://doi.org/10.1161/01.CIR.75.3.583
  9. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001;104:2797-802. https://doi.org/10.1161/hc4801.100076
  10. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006;114:1873-82. https://doi.org/10.1161/CIRCULATIONAHA.105.592063
  11. Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis 2010;5:354-65. https://doi.org/10.1111/j.1747-0803.2010.00435.x
  12. Celiker A, Aypar E, Karagoz T, Dilber E, Ceviz N. Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils. Catheter Cardiovasc Interv 2005;65:569-76. https://doi.org/10.1002/ccd.20423
  13. Jan SL, Hwang B, Fu YC, Chi CS. Transcatheter closure of a large patent ductus arteriosus in a young child using the Amplatzer duct occluder. Pediatr Cardiol 2005;26:703-6. https://doi.org/10.1007/s00246-004-0894-z
  14. Choi DY, Kim NY, Jung MJ, Kim SH. The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center. Korean Circ J 2010;40:230-4. https://doi.org/10.4070/kcj.2010.40.5.230
  15. Magee AG, Huggon IC, Seed PT, Qureshi SA, Tynan M. Transcatheter coil occlusion of the arterial duct; results of the European Registry. Eur Heart J 2001;22:1817-21. https://doi.org/10.1053/euhj.2001.2605
  16. Kim SY, Lee SH, Kim NK, Choi JY, Sul JH. A new strategy for transcatheter closure of patent ductus arteriosus with recent-generation devices. Korean J Pediatr 2009;52:488-93. https://doi.org/10.3345/kjp.2009.52.4.488
  17. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 2000;51:50-4. https://doi.org/10.1002/1522-726X(200009)51:1<50::AID-CCD11>3.0.CO;2-6
  18. Sivakumar K, Francis E, Krishnan P. Safety and feasibility of transcatheter closure of large patent ductus arteriosus measuring >or=4 mm in patients weighing https://doi.org/10.1111/j.1540-8183.2008.00348.x
  19. Wang JK, Wu MH, Lin MT, Chiu SN, Chen CA, Chiu HH. Transcatheter closure of moderate-to-large patent ductus arteriosus in infants using Amplatzer duct occluder. Circ J 2010;74:361-4. https://doi.org/10.1253/circj.CJ-09-0473
  20. Jung JW. Recent strategies and outcomes of transcatheter closure for patent ductus arteriosus. Korean Circ J 2010;40:216-8. https://doi.org/10.4070/kcj.2010.40.5.216
  21. Lee HJ, Sim GH, Jung KE, Lee JA, Choi CW, Kim EK, et al. Delayed closure effect in preterm infants with patent ductus arteriosus. Korean J Pediatr 2008;51:1065-70. https://doi.org/10.3345/kjp.2008.51.10.1065
  22. Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 2010;3:550-5.
  23. Thanopoulos BV, Eleftherakis N, Tzannos K, Stefanadis C, Giannopoulos A. Further experience with catheter closure of patent ductus arteriosus using the new Amplatzer duct occluder in children. Am J Cardiol 2010;105:1005-9. https://doi.org/10.1016/j.amjcard.2009.11.030
  24. Her K, Lee JW, Shin HK, Won YS. Video-Assisted Thoracoscopic Surgery for Patent Ductus Arteriosus. Korean Circ J 2004;34:978-82. https://doi.org/10.4070/kcj.2004.34.10.978

Cited by

  1. What is the optimal device for closure of a persistently patent ductus arteriosus? vol.33, pp.2, 2010, https://doi.org/10.1016/j.ppedcard.2012.02.005
  2. Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa vol.24, pp.6, 2013, https://doi.org/10.5830/cvja-2013-033
  3. Transcatheter closure of small ductus arteriosus with amplatzer vascular plug vol.56, pp.9, 2010, https://doi.org/10.3345/kjp.2013.56.9.396
  4. Evaluation of Left Ventricular Function by Tissue Doppler and Speckle-Derived Strain Rate Echocardiography after Percutaneous Ductus Closure vol.36, pp.1, 2010, https://doi.org/10.1007/s00246-014-0989-0
  5. Transcatheter Closure of Patent Ductus Arteriosus: 11 Years of Clinical Experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia vol.36, pp.5, 2010, https://doi.org/10.1007/s00246-015-1128-2
  6. Long‐term follow‐up is not indicated after routine interventional closure of persistent arterial ducts vol.86, pp.1, 2010, https://doi.org/10.1002/ccd.25912
  7. A Retrospective Study of 1526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus vol.128, pp.17, 2010, https://doi.org/10.4103/0366-6999.163398
  8. Cerebral Microemboli Detection and Differentiation During Transcatheter Closure of Patent Ductus Arteriosus vol.37, pp.6, 2010, https://doi.org/10.1007/s00246-016-1410-y
  9. Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus vol.26, pp.3, 2010, https://doi.org/10.5812/ijp.3621
  10. Clinical Outcome at One Year of Age Following Device Closure of Patent Ductus Arteriosus (PDA) in Small Babies vol.85, pp.7, 2018, https://doi.org/10.1007/s12098-018-2634-z
  11. The Outcomes of Transcatheter Closure in Patients with Patent Ductus Arteriosus at Haji Adam Malik General Hospital, Indonesia vol.9, pp.2, 2010, https://doi.org/10.3889/oamjms.2021.5764